Rubella vaccination: Must not be business as usual

The Lancet

Volumn 380, Issue 9838, 2012, Pages 217-218

  Cutts, F T ^a   Metcalf, C J E ^b   Lessler, J ^c   Grenfell, B T ^d  

^a Oxford University ^*  (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; RUBELLA VACCINE;

DIPHTHERIA; DISEASE TRANSMISSION; FUNDING; HEALTH PROGRAM; HUMAN; INCOME; INFECTION RISK; LETTER; PERTUSSIS; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RUBELLA; TETANUS; VACCINATION; ADOLESCENT; CHILD; INFANT; INTERNATIONAL COOPERATION; METHODOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INTERNATIONAL COOPERATION; RUBELLA; VACCINATION;

EID: 84864045035     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61215-X     Document Type: Letter

References (5)

1. Burki T. GAVI Alliance to roll out rubella vaccine. Lancet Infect Dis 2012; 12: 15-16.
2. Metcalf CJE, Lessler J, Klepac P, Cutts F, Grenfell BT. Minimum levels of coverage needed for rubella vaccination: impact of local demography, seasonality and population heterogeneity. Epidemiol Infect 2012; 16: 1-12.
3. WHO. Global measles and rubella strategic plan: 2012-2020. http://www.who.int/immunization/newsroom/Measles-Rubella- StrategicPlan-2012- 2020.pdf (accessed April 30, 2012).
4. WHO. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011; 86: 301-16.
5. Centers for Disease Control and Prevention. Measles outbreaks and progress toward measles preelimination\African region, 2009-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 374-78.